(Q42985317)

12 November 2017

title

Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes (English)

1 reference

12 November 2017

1 reference

1 reference

4

Harvey J Alter

1 reference

12 November 2017

5

J Wai-Kuo Shih

1 reference

12 November 2017

Xuanmao Jiao

1

1 reference

12 November 2017

Richard Yan-Hui Wang

series ordinal

2

1 reference

12 November 2017

Qi Qiu

series ordinal

3

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Journal of General Virology

12 November 2017

published in

1 reference

12 November 2017

volume

85

1 reference

12 November 2017

issue

Pt 6

1 reference

12 November 2017

page(s)

1545-1553

1 reference

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

12 November 2017

cites work

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Cytokine fields and the polarization of the immune response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Immune activation by bacterial DNA: a new genetic code

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

The scientific challenge of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

DNA Vaccination Protects Mice against Challenge withListeria monocytogenesExpressing the Hepatitis C Virus NS3 Protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

CpG motifs as immune adjuvants

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Type I interferon-mediated stimulation of T cells by CpG DNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Endotoxin removal from protein solutions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

A Toll-like receptor recognizes bacterial DNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/VIR.0.79896-0

Identifiers

DOI

10.1099/VIR.0.79896-0

1 reference

12 November 2017

1 reference